Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008
Published online before print March 20, 2008, doi: 10.1161/CIRCRESAHA.107.167072
A more recent version of this article appeared on May 9, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/9/1082    most recent
CIRCRESAHA.107.167072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Clarke, S. J.
Right arrow Articles by Halestrap, A. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, S. J.
Right arrow Articles by Halestrap, A. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Oxidant stress
Right arrow Cell signalling/signal transduction
Right arrow Energy metabolism
Right arrow Ischemic biology - basic studies

Submitted on July 4, 2007
Revised on February 8, 2008
Accepted on March 7, 2008

Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation

Samantha J. Clarke ; Igor Khaliulin ; Manika Das ; Joanne E. Parker ; Kate J. Heesom ; and Andrew P. Halestrap *

From the Department of Biochemistry and the Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

* To whom correspondence should be addressed. E-mail: a.halestrap{at}bristol.ac.uk.

Inhibition of mitochondrial permeability transition pore (MPTP) opening at reperfusion is critical for cardioprotection by ischemic preconditioning (IP). Some studies have implicated mitochondrial protein phosphorylation in this effect. Here we confirm that mitochondria rapidly isolated from preischemic control and IP hearts show no significant difference in calcium-mediated MPTP opening, whereas IP inhibits MPTP opening in mitochondria isolated from IP hearts following 30 minutes of global normothermic ischemia or 3 minutes of reperfusion. Analysis of protein phosphorylation in density-gradient purified mitochondria was performed using both 2D and 1D electrophoresis, with detection of phosphoproteins using Pro-Q Diamond or phospho-amino-specific antibodies. Several phosphoproteins were detected, including voltage-dependent anion channels isoforms 1 and 2, but none showed significant IP-mediated changes either before ischemia or during ischemia and reperfusion, and neither Western blotting nor 2D fluorescence difference gel electrophoresis detected translocation of protein kinase C ({alpha}, {varepsilon}, or {delta} isoforms), glycogen synthase kinase 3{beta}, or Akt to the mitochondria following IP. In freeze-clamped hearts, changes in phosphorylation of GSK3{beta}, Akt, and AMP-activated protein kinase were detected following ischemia and reperfusion but no IP-mediated changes correlated with MPTP inhibition or cardioprotection. However, measurement of mitochondrial protein carbonylation, a surrogate marker for oxidative stress, suggested that a reduction in mitochondrial oxidative stress at the end of ischemia and during reperfusion may account for IP-mediated inhibition of MPTP. The signaling pathways mediating this effect and maintaining it during reperfusion are discussed.


Key words: mitochondrial permeability transition • preconditioning • reperfusion injury • protein phosphorylation • oxidative stress




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Tanno and T. Miura
Adenine nucleotide translocator, a mitochondrial carrier protein, and fate of cardiomyocyte after ischaemia/reperfusion
Cardiovasc Res, August 25, 2008; (2008) cvn214v3.
[Full Text] [PDF]